Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Fish and Richardson
Cerilliant
Healthtrust
Express Scripts
Chinese Patent Office
Harvard Business School
Boehringer Ingelheim

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072050

« Back to Dashboard

NDA 072050 describes SULINDAC, which is a drug marketed by Ani Pharms Inc, Epic Pharma, Epic Pharma Llc, Fosun Pharma, Mylan, Sun Pharm Industries, and Watson Labs, and is included in twelve NDAs. It is available from twenty-one suppliers. Additional details are available on the SULINDAC profile page.

The generic ingredient in SULINDAC is sulindac. There are fourteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the sulindac profile page.
Summary for 072050
Tradename:SULINDAC
Applicant:Sun Pharm Industries
Ingredient:sulindac
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 072050
Medical Subject Heading (MeSH) Categories for 072050
Suppliers and Packaging for NDA: 072050
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULINDAC sulindac TABLET;ORAL 072050 ANDA Sun Pharmaceutical Industries, Inc. 53489-478 N 53489-478-01
SULINDAC sulindac TABLET;ORAL 072050 ANDA Sun Pharmaceutical Industries, Inc. 53489-478 N 53489-478-02

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength150MG
Approval Date:Apr 17, 1991TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
AstraZeneca
Cantor Fitzgerald
McKinsey
Harvard Business School
Express Scripts
Covington
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.